Oculomics Device Wins UK Funding - Takeaways - MDSpire

Oculomics Device Wins UK Funding

Occuity secures £1.5m grant for its eye-based diabetes screening device, SD1

  • July 20, 2026

  • 3 min

Share

  • 1

    Occuity secured a £1.5 million Innovate UK grant to develop a handheld device for diabetes and pre-diabetes screening.

  • 2

    The SD1 device uses oculomics to assess diabetes risk through a non-contact scan of the eye, eliminating the need for blood samples.

  • 3

    The device measures advanced glycation end-products in the crystalline lens, which are linked to long-term glucose exposure.

  • 4

    Diabetes poses significant challenges for the NHS, being a leading cause of kidney failure, blindness, and amputations.

  • 5

    Occuity's SD1 aims to enhance early identification of pre-diabetes risk and improve access to screening in community settings.

Original Source(s)

Oculomics Device Wins UK Funding

  • July 20, 2026

Related Content

AI Boosts Diabetic Eye Care Access

Recent study highlights how integrated AI-assisted DR screening in primary care clinics can improve access and decrease disparity

  • May 5, 2026

  • 3 min
AACE 2026: AI moves from hype to reality in diabetes care

"Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."

VesselMetaKAN: vessel-guided meta-learned interpretable classification for diabetic retinopathy grading